Amended Statement of Ownership (sc 13g/a)
11 Agosto 2022 - 4:53PM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE
13G/A
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED
PURSUANT TO § 240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO § 240.13d-2
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
RVL
Pharmaceuticals plc
(Name of Issuer)
Ordinary Shares, nominal value $0.01 per share
(Title of Class of Securities)
G6S41R101
(CUSIP Number)
August 8, 2022
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to
designate the rule pursuant to which this Schedule is filed:
| * |
The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form
with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. |
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities
Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
|
|
|
|
|
| CUSIP NO. G6S41R101 |
|
13G |
|
Page
2
of 13 Pages |
|
|
|
|
|
|
|
| 1 |
|
NAMES OF REPORTING PERSONS
ATHYRIUM OPPORTUNITIES IV ACQUISITION 2 LP |
| 2 |
|
CHECK THE APPROPRIATE BOX
IF A MEMBER OF A GROUP (a) ☐ (b) ☐
|
| 3 |
|
SEC USE ONLY
|
| 4 |
|
CITIZENSHIP OR PLACE OF
ORGANIZATION STATE OF DELAWARE, UNITED STATES OF
AMERICA |
|
|
|
|
|
|
|
| NUMBER OF
SHARES BENEFICIALLY
OWNED BY EACH
REPORTING PERSON
WITH |
|
5 |
|
SOLE VOTING POWER
0 Ordinary Shares |
| |
6 |
|
SHARED VOTING POWER
8,148,832 Ordinary Shares |
| |
7 |
|
SOLE DISPOSITIVE POWER
0 Ordinary Shares |
| |
8 |
|
SHARED DISPOSITIVE POWER
8,148,832 Ordinary
Shares |
|
|
|
|
|
|
|
| 9 |
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
8,148,832 Ordinary Shares |
| 10 |
|
CHECK BOX IF THE AGGREGATE
AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ☐ |
| 11 |
|
PERCENT OF CLASS
REPRESENTED BY AMOUNT IN ROW (9) 8.23% of the outstanding Ordinary
Shares |
| 12 |
|
TYPE OF REPORTING
PERSON PN |
|
|
|
|
|
| CUSIP NO. G6S41R101 |
|
13G |
|
Page
3
of 13 Pages |
|
|
|
|
|
|
|
| 1 |
|
NAMES OF REPORTING PERSONS
ATHYRIUM OPPORTUNITIES ASSOCIATES IV LP |
| 2 |
|
CHECK THE APPROPRIATE BOX
IF A MEMBER OF A GROUP (a) ☐ (b) ☐
|
| 3 |
|
SEC USE ONLY
|
| 4 |
|
CITIZENSHIP OR PLACE OF
ORGANIZATION STATE OF DELAWARE, UNITED STATES OF
AMERICA |
|
|
|
|
|
|
|
| NUMBER OF
SHARES BENEFICIALLY
OWNED BY EACH
REPORTING PERSON
WITH |
|
5 |
|
SOLE VOTING POWER
0 Ordinary Shares |
| |
6 |
|
SHARED VOTING POWER
8,148,832 Ordinary Shares |
| |
7 |
|
SOLE DISPOSITIVE POWER
0 Ordinary Shares |
| |
8 |
|
SHARED DISPOSITIVE POWER
8,148,832 Ordinary
Shares |
|
|
|
|
|
|
|
| 9 |
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
8,148,832 Ordinary Shares |
| 10 |
|
CHECK BOX IF THE AGGREGATE
AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ☐ |
| 11 |
|
PERCENT OF CLASS
REPRESENTED BY AMOUNT IN ROW (9) 8.23% of the outstanding Ordinary
Shares |
| 12 |
|
TYPE OF REPORTING
PERSON PN |
|
|
|
|
|
| CUSIP NO. G6S41R101 |
|
13G |
|
Page
4
of 13 Pages |
|
|
|
|
|
|
|
| 1 |
|
NAMES OF REPORTING PERSONS
ATHYRIUM OPPORTUNITIES ASSOCIATES IV GP LLC |
| 2 |
|
CHECK THE APPROPRIATE BOX
IF A MEMBER OF A GROUP (a) ☐ (b) ☐
|
| 3 |
|
SEC USE ONLY
|
| 4 |
|
CITIZENSHIP OR PLACE OF
ORGANIZATION STATE OF DELAWARE, UNITED STATES OF
AMERICA |
|
|
|
|
|
|
|
| NUMBER OF
SHARES BENEFICIALLY
OWNED BY EACH
REPORTING PERSON
WITH |
|
5 |
|
SOLE VOTING POWER
0 Ordinary Shares |
| |
6 |
|
SHARED VOTING POWER
8,148,832 Ordinary Shares |
| |
7 |
|
SOLE DISPOSITIVE POWER
0 Ordinary Shares |
| |
8 |
|
SHARED DISPOSITIVE POWER
8,148,832 Ordinary
Shares |
|
|
|
|
|
|
|
| 9 |
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
8,148,832 Ordinary Shares |
| 10 |
|
CHECK BOX IF THE AGGREGATE
AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ☐ |
| 11 |
|
PERCENT OF CLASS
REPRESENTED BY AMOUNT IN ROW (9) 8.23% of the outstanding Ordinary
Shares |
| 12 |
|
TYPE OF REPORTING
PERSON OO |
|
|
|
|
|
| CUSIP NO. G6S41R101 |
|
13G |
|
Page
5
of 13 Pages |
|
|
|
|
|
|
|
| 1 |
|
NAMES OF REPORTING PERSONS
ATHYRIUM OPPORTUNITIES IV CO-INVEST 2 LP |
| 2 |
|
CHECK THE APPROPRIATE BOX
IF A MEMBER OF A GROUP (a) ☐ (b) ☐
|
| 3 |
|
SEC USE ONLY
|
| 4 |
|
CITIZENSHIP OR PLACE OF
ORGANIZATION STATE OF DELAWARE. UNITED STATES OF
AMERICA |
|
|
|
|
|
|
|
| NUMBER OF
SHARES BENEFICIALLY
OWNED BY EACH
REPORTING PERSON
WITH |
|
5 |
|
SOLE VOTING POWER
0 Ordinary Shares |
| |
6 |
|
SHARED VOTING POWER
6,451,612 Ordinary Shares |
| |
7 |
|
SOLE DISPOSITIVE POWER
0 Ordinary Shares |
| |
8 |
|
SHARED DISPOSITIVE POWER
6,451,612 Ordinary
Shares |
|
|
|
|
|
|
|
| 9 |
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
6,451,612 Ordinary Shares |
| 10 |
|
CHECK BOX IF THE AGGREGATE
AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ☐ |
| 11 |
|
PERCENT OF CLASS
REPRESENTED BY AMOUNT IN ROW (9) 6.52% of the outstanding Ordinary
Shares |
| 12 |
|
TYPE OF REPORTING
PERSON PN |
|
|
|
|
|
| CUSIP NO. G6S41R101 |
|
13G |
|
Page
6
of 13 Pages |
|
|
|
|
|
|
|
| 1 |
|
NAMES OF REPORTING PERSONS
ATHYRIUM OPPORTUNITIES ASSOCIATES IV CO-INVEST LLC |
| 2 |
|
CHECK THE APPROPRIATE BOX
IF A MEMBER OF A GROUP (a) ☐ (b) ☐
|
| 3 |
|
SEC USE ONLY
|
| 4 |
|
CITIZENSHIP OR PLACE OF
ORGANIZATION STATE OF DELAWARE, UNITED STATES OF
AMERICA |
|
|
|
|
|
|
|
| NUMBER OF
SHARES BENEFICIALLY
OWNED BY EACH
REPORTING PERSON
WITH |
|
5 |
|
SOLE VOTING POWER
0 Ordinary Shares |
| |
6 |
|
SHARED VOTING POWER
6,451,612 Ordinary Shares |
| |
7 |
|
SOLE DISPOSITIVE POWER
0 Ordinary Shares |
| |
8 |
|
SHARED DISPOSITIVE POWER
6,451,612 Ordinary
Shares |
|
|
|
|
|
|
|
| 9 |
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
6,451,612 Ordinary Shares |
| 10 |
|
CHECK BOX IF THE AGGREGATE
AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ☐ |
| 11 |
|
PERCENT OF CLASS
REPRESENTED BY AMOUNT IN ROW (9) 6.52% of the outstanding Ordinary
Shares |
| 12 |
|
TYPE OF REPORTING
PERSON OO |
|
|
|
|
|
| CUSIP NO. G6S41R101 |
|
13G |
|
Page
7
of 13 Pages |
|
|
|
|
|
|
|
| 1 |
|
NAMES OF REPORTING PERSONS
ATHYRIUM FUNDS GP HOLDINGS LLC |
| 2 |
|
CHECK THE APPROPRIATE BOX
IF A MEMBER OF A GROUP (a) ☐ (b) ☐
|
| 3 |
|
SEC USE ONLY
|
| 4 |
|
CITIZENSHIP OR PLACE OF
ORGANIZATION STATE OF DELAWARE, UNITED STATES OF
AMERICA |
|
|
|
|
|
|
|
| NUMBER OF
SHARES BENEFICIALLY
OWNED BY EACH
REPORTING PERSON
WITH |
|
5 |
|
SOLE VOTING POWER
0 Ordinary Shares |
| |
6 |
|
SHARED VOTING POWER
14,600,444 Ordinary Shares |
| |
7 |
|
SOLE DISPOSITIVE POWER
0 Ordinary Shares |
| |
8 |
|
SHARED DISPOSITIVE POWER
14,600,444 Ordinary
Shares |
|
|
|
|
|
|
|
| 9 |
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
14,600,444 Ordinary Shares |
| 10 |
|
CHECK BOX IF THE AGGREGATE
AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ☐ |
| 11 |
|
PERCENT OF CLASS
REPRESENTED BY AMOUNT IN ROW (9) 14.75% of the outstanding Ordinary
Shares |
| 12 |
|
TYPE OF REPORTING
PERSON OO |
|
|
|
|
|
| CUSIP NO. G6S41R101 |
|
13G |
|
Page
8
of 13 Pages |
|
|
|
|
|
|
|
| 1 |
|
NAMES OF REPORTING PERSONS
Jeffrey A. Ferrell |
| 2 |
|
CHECK THE APPROPRIATE BOX
IF A MEMBER OF A GROUP (a) ☐ (b) ☐
|
| 3 |
|
SEC USE ONLY
|
| 4 |
|
CITIZENSHIP OR PLACE OF
ORGANIZATION UNITED STATES OF
AMERICA |
|
|
|
|
|
|
|
| NUMBER OF
SHARES BENEFICIALLY
OWNED BY EACH
REPORTING PERSON
WITH |
|
5 |
|
SOLE VOTING POWER
0 Ordinary Shares |
| |
6 |
|
SHARED VOTING POWER
14,600,444 Ordinary Shares |
| |
7 |
|
SOLE DISPOSITIVE POWER
0 Ordinary Shares |
| |
8 |
|
SHARED DISPOSITIVE POWER
14,600,444 Ordinary
Shares |
|
|
|
|
|
|
|
| 9 |
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
14,600,444 Ordinary Shares |
| 10 |
|
CHECK BOX IF THE AGGREGATE
AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ☐ |
| 11 |
|
PERCENT OF CLASS
REPRESENTED BY AMOUNT IN ROW (9) 14.75% of the outstanding Ordinary
Shares |
| 12 |
|
TYPE OF REPORTING
PERSON IN |
|
|
|
|
|
| CUSIP NO. G6S41R101 |
|
13G |
|
Page
9
of 13 Pages |
| Item 1(a). |
Name of Issuer: |
RVL Pharmaceuticals plc (the “Issuer”)
| Item 1(b). |
Address of Issuer’s Principal Executive Offices: |
400 Crossing Boulevard
Bridgewater, New Jersey 08807
| Item 2(a). |
Name of Person Filing: |
This statement (this “Statement”) is filed by the following persons (the “Reporting Persons”):
Athyrium Opportunities IV Acquisition 2 LP (“Acquisition Fund”)
Athyrium Opportunities Associates IV LP (“Associates IV LP”)
Athyrium Opportunities Associates IV GP LLC (“Associates IV GP”)
Athyrium Opportunities IV Co-Invest 2 LP (“Co-Invest 2
LP”)
Athyrium Opportunities Associates IV Co-Invest LLC (“Co-Invest LLC”)
Athyrium Funds GP Holdings LLC (“Funds GP Holdings”)
Jeffrey A. Ferrell (“Mr. Ferrell”)
The Reporting Persons’ beneficial ownership of the Issuer’s Ordinary Shares reported herein consist of ordinary shares, nominal value
$0.01 per share, held directly by Acquisition Fund and Co-Invest 2 LP.
Pursuant to Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the Reporting Persons have entered into an agreement with respect to the joint filing of this Statement, which agreement is set forth on
the signature page to this Statement.
| Item 2(b). |
Address of Principal Business Office or, if none, Residence: |
The principal business office address for each of the Reporting Persons is:
c/o Athyrium Capital Management, LP
505 Fifth Avenue, Floor 18
New
York, New York 10017
Acquisition Fund, Co-Invest 2 LP and Associates IV LP are Delaware limited partnerships.
Associates IV GP, Co-Invest LLC and Funds GP Holdings are Delaware limited liability companies.
Mr. Ferrell is a United States citizen.
| Item 2(d). |
Title of Class of Securities: |
Ordinary Shares, nominal value $0.01 per share, of the Issuer (the “Ordinary Shares”)
G6S41R101
|
|
|
|
|
| CUSIP NO. G6S41R101 |
|
13G |
|
Page
10
of 13 Pages |
| Item 3. |
If this statement is filed pursuant to §§ 240.13d-1(b), or
240.13d-2(b) or (c), check whether the person filing is a: |
Not applicable.
Filed pursuant to Rule 13d-1(c).
| |
(a) |
Amount beneficially owned: |
The Reporting Persons beneficially own in the aggregate 14,600,444 Ordinary Shares. In addition, certain of the Reporting Persons
beneficially own warrants (the “Warrants”) to purchase 2,000,000 Ordinary Shares. However, because the terms of the Warrants limit the exercise of the Warrants while the Reporting Persons’ beneficial ownership of the Issuer’s
Ordinary Shares exceeds 9.9% of the outstanding Ordinary Shares, the Warrants held by the Reporting Persons do not represent a right to receive Ordinary Shares within 60 days of the date of this Statement and therefore none of the shares issuable
upon exercise of the Warrants are included herein.
See the responses to Item 11 on the attached cover pages.
| |
(c) |
Number of shares as to which the person has: |
| |
(i) |
Sole power to vote or to direct the vote: |
See the responses to Item 5 on the attached cover pages.
| |
(ii) |
Shared power to vote or to direct the vote: |
See the responses to Item 6 on the attached cover pages.
| |
(iii) |
Sole power to dispose or to direct the disposition of: |
See the responses to Item 7 on the attached cover pages.
| |
(iv) |
Shared power to dispose or to direct the disposition of: |
See the responses to Item 8 on the attached cover pages.
The filing of this Statement shall not be deemed an admission that the Reporting Persons are, for purposes of Section 13(d) of the
Securities Exchange Act of 1934, as amended, the beneficial owners of any securities of the Issuer that he or it does not directly own. Each of the Reporting Persons specifically disclaims beneficial ownership of the securities reported herein that
he or it does not directly own.
| Item 5. |
Ownership of Five Percent or Less of a Class. |
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of
more than 5 percent of the class of securities, check the following ☐.
|
|
|
|
|
| CUSIP NO. G6S41R101 |
|
13G |
|
Page
11
of 13 Pages |
| Item 6. |
Ownership of More Than Five Percent on Behalf of Another Person. |
Not applicable.
| Item 7. |
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the
Parent Holding Company or Control Person. |
Not applicable.
| Item 8. |
Identification and Classification of Members of the Group. |
Not applicable.
| Item 9. |
Notice of Dissolution of Group. |
Not applicable.
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held
for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than
activities solely in connection with a nomination under § 240.14a-11.
|
|
|
|
|
| CUSIP NO. G6S41R101 |
|
13G |
|
Page
12
of 13 Pages |
SIGNATURES
After reasonable inquiry and to the best of each of the undersigned’s knowledge and belief, each of the undersigned certifies that the information set
forth in this Statement is true, complete and correct.
In accordance with Rule 13d-1(k)(1)(iii) under the
Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of this Statement on Schedule 13G with respect to the Ordinary Shares of the Issuer.
Dated: August 11, 2022
|
|
|
|
|
| ATHYRIUM OPPORTUNITIES IV ACQUISITION 2 LP |
|
|
| By: |
|
ATHYRIUM OPPORTUNITIES ASSOCIATES IV LP, its General Partner |
|
|
|
|
|
By: |
|
ATHYRIUM OPPORTUNITIES ASSOCIATES IV GP LLC, its General Partner |
|
|
|
|
|
By: |
|
/s/ Andrew Hyman |
|
|
Name: |
|
Andrew Hyman |
|
|
Title: |
|
Senior Vice President, Secretary |
|
|
|
| ATHYRIUM OPPORTUNITIES ASSOCIATES IV LP |
|
|
| By: |
|
ATHYRIUM OPPORTUNITIES ASSOCIATES IV GP LLC, its General Partner |
|
|
| By: |
|
/s/ Andrew Hyman |
| Name: |
|
Andrew Hyman |
| Title: |
|
Senior Vice President, Secretary |
|
| ATHYRIUM OPPORTUNITIES ASSOCIATES IV GP LLC |
|
|
| By: |
|
/s/ Andrew Hyman |
| Name: |
|
Andrew Hyman |
| Title: |
|
Senior Vice President, Secretary |
|
|
|
|
|
| CUSIP NO. G6S41R101 |
|
13G |
|
Page
13
of 13 Pages |
|
|
|
| ATHYRIUM OPPORTUNITIES IV CO-INVEST 2 LP |
|
| By: ATHYRIUM OPPORTUNITIES ASSOCIATES IV CO-INVEST LLC, its General Partner |
|
|
| By: |
|
/s/ Andrew Hyman |
| Name: |
|
Andrew Hyman |
| Title: |
|
Senior Vice President, Secretary |
|
| ATHYRIUM OPPORTUNITIES ASSOCIATES IV CO-INVEST LLC |
|
|
| By: |
|
/s/ Andrew Hyman |
| Name: |
|
Andrew Hyman |
| Title: |
|
Senior Vice President, Secretary |
|
| ATHYRIUM FUNDS GP HOLDINGS LLC |
|
|
| By: |
|
/s/ Jeffrey A. Ferrell |
| Name: |
|
Jeffrey A. Ferrell |
| Title: |
|
Managing Member |
|
| /s/ Jeffrey A. Ferrell |
| JEFFREY A. FERRELL |
Osmotica Pharmaceuticals (NASDAQ:OSMT)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024
Osmotica Pharmaceuticals (NASDAQ:OSMT)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024
